SynthesisFrontiers in oncology2022

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis.

Xiao-Fang Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.